Trial Profile
Pharmacokinetics interaction study of MK-5172 and Efavirenz
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Grazoprevir (Primary)
- Indications Hepatitis C; HIV-1 infections
- Focus Pharmacokinetics
- 05 Dec 2015 New trial record